Methamphetamine: Epidemiological and Research Implications for the Legal Field by Maxwell, Jane Carlisle
North Dakota Law Review 
Volume 82 
Number 4 Methamphetamine: Casting A 
Shadow Across Disciplines And Jurisdictions 
Article 1 
1-1-2006 
Methamphetamine: Epidemiological and Research Implications 
for the Legal Field 
Jane Carlisle Maxwell 
Follow this and additional works at: https://commons.und.edu/ndlr 
 Part of the Law Commons 
Recommended Citation 
Maxwell, Jane Carlisle (2006) "Methamphetamine: Epidemiological and Research Implications for the 
Legal Field," North Dakota Law Review: Vol. 82 : No. 4 , Article 1. 
Available at: https://commons.und.edu/ndlr/vol82/iss4/1 
This Article is brought to you for free and open access by the School of Law at UND Scholarly Commons. It has 
been accepted for inclusion in North Dakota Law Review by an authorized editor of UND Scholarly Commons. For 
more information, please contact zeineb.yousif@library.und.edu. 
     
 
METHAMPHETAMINE: 
EPIDEMIOLOGICAL AND RESEARCH IMPLICATIONS 
FOR THE LEGAL FIELD 
DR. JANE CARLISLE MAXWELL∗ 
I. INTRODUCTION 
The methamphetamine epidemic continues to spread across the United 
States, which signifies an increasing need for effective treatment.  In 
addition to the already-documented physical effects of the drug, preliminary 
evidence suggests methamphetamine dependence may cause long-term 
neuronal damage.  Recently abstinent users have been found to do poorly 
on tests of attention and motor skills, which are factors that can adversely 
affect treatment outcomes.  Methamphetamine use is also implicated in 
aggression and violence and it also affects the children and adults who are 
exposed to the behaviors of methamphetamine users as well as to toxic 
chemicals at laboratory sites.  Outpatient treatment programs, such as the 
Matrix Model, are effective. 
II. THE EPIDEMIC OF METHAMPHETAMINE ABUSE 
A. TYPES OF METHAMPHETAMINE 
The methamphetamine epidemic is characterized both by type and 
location.  Methamphetamine is made from ephedrine or pseudoephedrine.1  
In many parts of the United States, the problems first began with the “home 
cooking” of methamphetamine using cold allergy products which contained 
pseudoephedrine.2  Methamphetamine produced in this powder form is 
 
 ∗Jane Carlisle Maxwell has a Ph.D. in Public Policy from the University of Texas at Austin 
and A.B. and M.A. degrees from the University of South Carolina.  She is director of the Center 
for Excellence in Epidemiology in the Gulf Coast Addiction Technology Transfer Center.  She has 
been a member of the HHS Substance Abuse and Mental Health Services National Advisory 
Council and is a member of the Drug Abuse Advisory Committee to the Food and Drug 
Administration’s Center for Drug Evaluation and Research.  She is also a member of the National 
Institute on Drug Abuse’s Community Epidemiology and Border Epidemiology Work Groups, the 
College on Problems of Drug Dependence, the Research Society on Alcoholism, and the 
International Council on Alcohol, Drugs, and Traffic Safety.  She is a Fulbright Senior Specialist 
and a Visiting Fellow at the Centre for Accident Research, Queensland University of Technology, 
in Brisbane, Australia. 
1. Jane Carlisle Maxwell, Emerging Research on Methamphetamine, 18 CURRENT OPINION 
IN PSYCHIATRY 235, 235 (2005). 
2. See id. (identifying California as a source of methamphetamine). 
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usually inhaled, injected, or swallowed.3  According to the United States 
Drug Enforcement Administration (DEA), the price of a gram of powder 
methamphetamine has declined from $20-$600 in 2002 to $20-$300 in 
2005.4 
The production of powder methamphetamine in small laboratories has 
decreased with the recent state and federal regulations limiting access to 
large quantities of over-the-counter pseudoephedrine products.5  However, 
the locally-produced methamphetamine has been replaced with large quan-
tities of higher-purity methamphetamine powder and crystalline “Ice” from 
Mexico.6  Ice, also called “Crystal Meth,” “Shards,” or “Tina,” looks like 
pieces of glass or rock candy, without significant powder present.  The 
price of a gram of Ice across the United States has decreased from $120-
$700 in 2002 to $30-$700 in 2005.7  With the increasing presence of the 
purer forms of methamphetamine, the DEA reports the average purity has 
increased from 49% to 69% between 2002 and 2005.8 
Ice is usually smoked in a pipe, or the vapors are inhaled as the Ice 
smolders on tinfoil held over heat.9  The increasing popularity of Ice is 
shown by the fact that smoking has become the most common route of 
administration reported by individuals entering treatment with a primary 
problem with any form of methamphetamine.10  In 1994, only 15% of 
methamphetamine admissions smoked the drug, but by 2004, 59% were 
 
3. Id. 
4. Drug Enforcement Admin., Domestic Strategic Unit, U.S. Dep’t of Justice, Cocaine and 
Methamphetamine Price and Purity: 2002 to 2005 11 (Oct. 25, 2006) [hereinafter Price and 
Purity] (unpublished manuscript on file with author). 
5. See USA PATRIOT Improvement and Reauthorization Act of 2005, Pub. L. No. 109-177, 
120 Stat. 192 (providing federal legislation on methamphetamine); OFFICE OF NAT’L DRUG CON-
TROL POLICY, PUSHING BACK AGAINST METH: A PROGRESS REPORT ON THE FIGHT AGAINST 
METHAMPHETAMINE IN THE UNITED STATES (2006), http://www.whitehousedrugpolicy.gov/ 
publications/pdf/pushingback_against_meth.pdf (describing the status of legislation in each of the 
fifty states and comparing the state restrictions to the Combat Methamphetamine Epidemic Act 
Standards of 2006). 
6. NAT’L DRUG INTELLIGENCE CTR., U.S. DEP’T OF JUSTICE, PUBL’N NO. 2006-Q0317-004, 
NATIONAL METHAMPHETAMINE THREAT ASSESSMENT 2007 2 (2006), available at 
http://www.usdoj.gov/ndic/pubs21/21821/index.htm.   
7. Price and Purity, supra note 5, at 14. 
8. Id. at 9. 
9. Maxwell, supra note 1, at 235. 
10. OFFICE OF APPLIED STUDIES, SUBSTANCE ABUSE & MENTAL HEALTH SERVS. ADMIN., 
PUBL’N NO. (SMA) 06-4180, TREATMENT EPISODE DATA SET (TEDS) 1994-2004: NATIONAL 
ADMISSIONS TO SUBSTANCE ABUSE TREATMENT SERVICES 24 (2006) [hereinafter TREATMENT 
EPISODE DATA SET 1996-2004], available at http://www.dasis.samhsa.gov./teds04/ 
tedsad2k4web.pdf; OFFICE OF APPLIED STUDIES, SUBSTANCE ABUSE & MENTAL HEALTH SERVS. 
ADMIN., PUBL’N NO. (SMA) 01-3550, TREATMENT EPISODE DATA SET (TEDS) 1994-1999: 
NATIONAL ADMISSIONS TO SUBSTANCE ABUSE TREATMENT SERVICES 26 (2001), available at 
http://www.dasis.samhsa.gov/teds99/1999teds_vpt._pdf. [hereinafter TREATMENT EPISODE DATA 
SET 1994-1999]. 
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smoking it.11  The proportion inhaling or snorting methamphetamine 
dropped from 43% to 14%, and injecting as the route of administration 
dropped from 29% to 21% in the same period.12 
B. THE SPREAD OF THE METHAMPHETAMINE EPIDEMIC IN THE 
UNITED STATES 
The methamphetamine epidemic began in the western states and 
continues to be a larger problem there.  In California, the rate of treatment 
admissions per 100,000 went from 96 in 1994 to 204 in 2004, while in 
Wyoming, it went from 26 to 205 in the same time period.13  Use has 
increased in the southern states, with the rate per 100,000 in Georgia going 
from three in 1994 to forty in 2004, and admissions are increasing in the 
eastern states, with the rate per 100,000 in Maine increasing from two in 
1994 to five in 2004.14 
Among all methamphetamine admissions in 2004, 33% were treated in 
large central metropolitan areas, 21% in large fringe metropolitan areas, 
31% percent in small metropolitan areas, 9% in non-metropolitan areas with 
a city, and 6% in non-metropolitan areas without a city (rural).15  The route 
of administration differed by rural/urban status: the percentage of admis-
sions that smoked the drug was highest in the most urbanized areas (62%) 
and lowest in the most rural areas (48%).16  In contrast, the percentage of 
admissions that injected the drugs was lowest in large metropolitan areas 
(between 14% and 15%) and highest in small and non-metropolitan areas 
(between 24% and 25%), which reflects the presence of Ice in the 
metropolitan areas and powder in the smaller and non-metropolitan areas.17 
The National Survey on Drug Use and Health (NSDUH) reported that 
each year between 2002 and 2005, there are over a half million persons ages 
twelve and older living in households who had used methamphetamine in 
the past month.18  This survey found that these users were becoming highly 
impaired, with the percentage reporting no abuse or dependence on illicit 
 
11. TREATMENT EPISODE DATA SET 1994-1999, supra note 10, at 42. 
12. Id. 
13. Id. at 92-93. 
14. Id. at 92. 
15. SUBSTANCE ABUSE & MENTAL HEALTH ADMIN., THE DASIS REPORT: 
METHAMPHETAMINE/AMPHETAMINE TREATMENT ADMISSIONS IN URBAN AND RURAL AREAS: 
2004 27 (2006), available at http://www.oas.samsa.gv/2k6/methRuralTX/methRuralTX.pdf. 
16. Id. 
17. Id. 
18. OFFICE OF APPLIED STUDIES, DEP’T OF HEALTH & HUMAN SERVICES, PUBL’N NO. 
SMA 06-4194, RESULTS FROM THE 2005 NATIONAL SURVEY ON DRUG USE AND HEALTH: 
NATIONAL FINDINGS 16 (2006), available at http://oas.samhsa.gov/nsduh/2k5results.pdf. 
      
1124 NORTH DAKOTA LAW REVIEW [VOL. 82:1121 
drugs dropping from 73% in 2002 to 50% in 2005.19  On the other hand, the 
proportion abusing or dependent on methamphetamine rose from 11% to 
20% between 2002 and 2005, and the proportion reporting abuse or 
dependence on other drugs rose from 17% to 30%.20  
One of the problems in monitoring trends and patterns in the use of 
methamphetamine is that the distinctions between the different types of 
amphetamine type substances (ATS) and routes of administration are often 
not clear.21  This is partially due to the fact that a toxicological screen is a 
rapid test that provides only a preliminary analytical result of the presence 
of a substance.  A confirmatory test, which is a more specific chemical 
method, must be used in order to obtain a confirmed result.  To differentiate 
methamphetamine from ATS such as ecstasy or amphetamine, a con-
firmatory test such as gas chromatography and mass spectrometry (GC-MS) 
is necessary.22 
III. THE ADVERSE EFFECTS OF METHAMPHETAMINE USE 
A. EFFECTS ON USERS 
The motivations for using methamphetamine reported by 28% of 
clients admitted for treatment in Los Angeles County included the belief 
that methamphetamine was a better, cheaper, and safer alternative than 
other stimulants on which they had been dependent.23  An additional 28% 
used methamphetamine as a crutch to help them cope with mental illness, 
distress, or trauma so that they felt “normal.”24  Twenty-three percent 
primarily used the drug to stay awake longer and to gain strength and 
energy, while 11% used it to enhance sexual experience and performance.  
For 10%, methamphetamine was used as a tool to lose weight.25 
In the short-term, methamphetamine causes increases in heart rate, 
blood pressure, temperature, rate of breathing, constriction of blood vessels, 
 
19. OFFICE OF APPLIED STUDIES, DEP’T OF HEALTH & HUMAN SERVICES, METHAMPHET-
AMINE DEPENDENCE/ABUSE AND TREATMENT tbl.2, available at http://www.oas.samhsa.gov/ 
methTabs.htm (last visited June 25, 2007). 
20. Id. 
21. JANE CARLISLE MAXWELL, UNIV. OF TEX. CTR. SOC. WORK. RES., IMPLICATIONS OF 
RESEARCH FOR TREATMENT: METHAMPHETAMINE 1 (2005), available at http://www.utexas.edu/ 
research/cswr/gcattc/Methamphetamine.pdf [hereinafter MAXWELL, RESEARCH FOR 
TREATMENT]. 
22. See generally Maxwell, supra note 1, at 235-42. 
23. Christine Von Mayrhauser et al., Use Ecology and Drug Use Motivations of 
Methamphetamine Users Admitted to Substance Abuse Treatment Facilities in Los Angeles: An 
Emerging Profile, 21 J. ADDICTIVE DISEASES 45, 33-54 (2002). 
24. Id. at 54-55. 
25. Id. at 56-57. 
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and cardiac arrhythmia.26  Over longer periods of time, methamphetamine 
use is associated with health problems such as stroke, cardiac valve 
thickening, and decreases in lung function.27  Prolonged use also causes 
pulmonary hypertension, changes to the brain, poor cognitive functioning, 
and poor mental health.28 
A survey of “Ice” or “crystal meth” users in Sydney, Australia, found 
the users reported benefits that included alertness, energy, aphrodisiac 
effects, sociability, euphoria, and loss of inhibitions.29  Although most peo-
ple in the survey did not have extensive experience with Ice, they reported 
high rates of physical and psychological side effects, including “come-
down,” paranoia, inability to sleep, addiction, and aggression.30  Compared 
with a sample of longer-term, heavier, and predominately injecting 
amphetamine users, crystal methamphetamine users appeared more likely to 
experience significant harms after a much shorter and lower level of use.31 
The 2003 Australian Party Drug Survey found that Ice users, as 
compared to users of powder or other forms of methamphetamine, were 
significantly more likely to report that they had “binged” on stimulants in 
the past six months (i.e., used the drug continuously for more than forty-
eight hours without sleep).32  Similarly, Ice users reported that drug use 
caused social, work, and financial problems.33  In addition, recent Ice 
injectors were significantly more likely to have sought treatment for mental 
health problems in the last six months, with the most common problems 
being depression and anxiety.34 
 
26. See Maxwell, supra note 1, at 235-42 (explaining that arrhythmia is an irregularity in the 
force or rhythm of the heartbeat). 
27. Id. 
28. Lisa Greenwell & Mary-Lynn Brecht, Self-reported Health Status Among Treated 
Methamphetamine Users, 29 AM. J. DRUG & ALCOHOL ABUSE 75, 75-104 (2003). 
29. Louisa Degenhardt & Libby Topp, “Crystal meth” Use Among Polydrug Users in 
Sydney’s Dance Party Subculture: Characteristics, Use Patterns and Associated Harm, 14 INT’L 
J. DRUG POL’Y 17, 17-24 (2002). 
30. Id. at 23.  
31. Id. 
32. COURTNEY BREEN ET AL., NAT’L DRUG & ALCOHOL RES. CTR., AUSTRALIAN PARTY 
DRUG TRENDS 3 (2004), available at http://ndarc.med.unsw.edu.au/NDARCWeb.nsf/page/ 
monographs (follow link to monograph 52). 
33. Id. at 92. 
34. COURTNEY BREEN ET AL., NAT’L DRUG & ALCOHOL RES. CTR., CRYSTALLINE METH-
AMPHETAMINE (ICE) USE IN THE 2003 IDRS 3 (2004), available at http://ndarc.med.unsw.edu.au/ 
NDARCWeb.nsf/resources/BulletinIDRS 2004/$file/IDRS+bulletin+Apirl+2004.pdf. 
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B. PSYCHIATRIC EFFECTS AND VIOLENCE 
Methamphetamine abuse adversely impacts social support and social 
networks and behavioral functioning.35  It produces a variety of effects: 
irritability, physical aggression, hyperawareness, hypervigilance, and 
psychomotor agitation, are only some of its several effects.36  Chronic 
intoxication can produce a psychotic paranoid state with frightening delu-
sions that may result in aggressive acts.37  With increased dosage and 
duration of administration, amphetamines can produce delirium, which is 
manifested by disorientation, confusion, fear and anxiety.38  During high-
dose use, individuals can experience stimulant-induced psychosis character-
ized by delusions, paranoid thinking, and compulsive behavior.39  There is 
also substantial evidence to associate the effects of its use with violence.40 
The Methamphetamine Treatment Project (MTP) in California found 
that participants had high levels of psychiatric symptoms, particularly 
depression and attempted suicide, as well as anxiety and psychotic symp-
toms.41  The MTP reported high levels of problems among participants, 
such as controlling anger and violent behavior, with a correspondingly high 
frequency of assault and weapons charges.42 
Past and current interpersonal violence is a characteristic of the 
lifestyles of the majority entering treatment for methamphetamine depend-
ence.43  Persons in treatment for methamphetamine reported high rates of 
being victims of violence (85% of reporting women and 69% of reporting 
men).44  For women, the most common source of violence was their partner 
(80%), while for men it was a stranger (43%).45  These clients also had a 
 
35. Margaret Cretzmeyer et al., Treatment of Amphetamine Abuse: Research Findings and 
Clinical Directions, 24 J. SUBSTANCE ABUSE TREATMENT 267, 268 (2003). 
36. See MAXWELL, RESEARCH FOR TREATMENT, supra note 21, at 1 (providing that hyper-
vigilance means the condition of maintaining an abnormal awareness of environmental stimuli). 
37. Id. 
38. Id. 
39. Id.  Psychosis—a mental and behavioral disorder in which reality is grossly distorted.  
Symptoms can include seeing, hearing, smelling, or tasting things that are not there; paranoia; 
delusions.  Psychosis can occur as a result of brain injury or disease, and is seen particularly in 
schizophrenia and bipolar disorders.  STEDMAN’S MEDICAL DICTIONARY 1478 (27th ed. 2000). 
40. Sharon M. Boles & Karen Miotto, Substance Abuse and Violence: A Review of the 
Literature, 8 AGGRESSION & VIOLENT BEHAV. 155, 160 (2003). 
41. Joan E. Zweben et al., Psychiatric Symptoms in Methamphetamine Users, 13 AM. J. 
ADDICTION 181, 181 (2004). 
42. Id. at 185. 
43. Judith B. Cohen et al., Abuse and Violence History of Men and Women in Treatment for 
Methamphetamine Dependence, 12 AM. J. ADDICTIONS 377, 380 (2003). 
44. Id. 
45. Id. 
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history of being the victim of sexual abuse (57% of reporting women and 
16% of reporting men).46 
A study of methamphetamine users paroled from California state 
prisons found methamphetamine use to be significantly predictive of self-
reported violent criminal behavior and general recidivism (i.e., a return to 
custody for any reason).47  However, it was not significantly predictive of 
being returned to custody for a violent offense.48  Methamphetamine users 
may differ significantly from non-methamphetamine users and may be in 
need of more intensive treatment interventions and parole supervision than 
other types of offenders who use drugs.49 
C. ADDITIONAL RISKS FOR THE USER 
Methamphetamine at higher doses impairs driving skills and may cause 
hypersomnolence at the end-of-binge.50  In addition, younger drivers were 
more often judged impaired than older drivers who had similar blood 
amphetamine concentrations.51 
Many methamphetamine users are at high risk of sexually transmitted 
and blood-borne diseases.52  A study of 139 HIV-negative methampheta-
mine-dependent heterosexuals found they used the drug to get high, to get 
more energy, and to party.53  Those studied reused syringes, shared needles, 
drank alcohol daily, used other drugs, had unprotected sex, had multiple sex 
partners (the average was 9.4 in the past two months), and engaged in 
marathon sex.54 
Use of methamphetamine, and particularly Ice, has increased among 
men who have sex with other men.55  Ice appears to be especially sexually 
arousing and causes loss of inhibitions; it is strongly associated with sexual 
 
46. Id. 
47. Jerome Cartier et al., Methamphetamine Use, Self-Reported Violent Crime, and 
Recidivism Among Offenders in California Who Abuse Substances, 21 J. INTERPERSONAL 
VIOLENCE 435, 438-39 (2006). 
48. Id. at 440. 
49. Id. at 443. 
50. See Ingebjorge Gustavsen et al., Impairment Related to Blood Amphetamine and/or 
Methamphetamine Concentrations in Suspected Drugged Drivers, 38 ACCIDENT ANALYSIS & 
PREVENTION 490, 493 (2006) (providing that hypersomnolence means excessive sleepiness, 
especially in daytime). 
51. Id. 
52. MAXWELL, RESEARCH FOR TREATMENT, supra note 21, at 2. 
53. Shirley Semple et al., The Context of Sexual Risk Behavior Among Heterosexual 
Methamphetamine Users, 29 ADDICTIVE BEHAVS. 807, 807-08 (2004). 
54. Id. 
55. Steven P. Kurtz & James A. Inciardi, Crystal Meth, Gay Men, and Circuit Parties, 3 L. 
ENFORCEMENT EXECUTIVE FORUM 97-114 (2003). 
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behaviors that put users at risk for HIV infection.56  Homosexual and 
bisexual men may use Ice to “initiate, enhance, and prolong sexual 
encounters and intoxication can lead to lapses in judgment with regard to 
safe sex.”57  Methamphetamine and sex are not only integrally connected, 
but participants report that sex while on methamphetamine is “compulsive” 
and “obsessive,” and causes loss of control over sexual expression.58 
In addition, methamphetamine is sometimes used in combination with 
a wide variety of other drugs including alcohol, cocaine, ecstasy, ketamine, 
and gamma hydroxybutyrate (GHB), which increases the risk of overdose 
and other adverse events.59  Medical complications for methamphetamine 
abuse in HIV-infected patients include hypertension, hyperthermia, rhab-
domyolysis, and stroke, and psychiatric problems in methamphetamine 
abusers with HIV infection include acute psychotic reactions and long-term 
depression.60 
Furthermore, methamphetamine use during pregnancy may affect the 
developing fetus.61  The first large-scale investigation is underway to report 
the prevalence of methamphetamine use during pregnancy and the out-
comes associated with prenatal methamphetamine exposure.62  Therefore, 
caution should be exercised in inferring the extent of harm until this 
National Institute on Drug Abuse-funded study on prenatal methampheta-
mine exposure and child development is completed. 
 
56. Id. 
57. Antonio Urbina & Kristine Jones, Crystal Methamphetamine, Its Analogues, and HIV 
Infection: Medical and Psychiatric Aspects of a New Epidemic, 38 CLINICAL INFECTIOUS 
DISEASES: HIV/AIDS 890, 890 (2003). 
58. Cathy Reback et al., Changes in the Meaning of Sexual Risk Behaviors Among Gay and 
Bisexual Male Methamphetamine Abusers Before and After Drug Treatment, 8 AIDS BEHAV. 87, 
90 (2004). 
59. Michael Ross et al., Club Drugs and Sex on Drugs are Associated with Different 
Motivations for Gay Circuit Party Attendance in Men, 38 SUBSTANCE USE AND MISUSE 1173, 
1174 (2003). 
60. Id.  Hypertension means high blood pressure. STEDMAN’S MEDICAL DICTIONARY, supra 
note 39, at 855.  Hyperthermia means exceptionally high fever.  Id. at 856.  Rhabdomyolysis 
means the breakdown of muscle fibers with leakage of potentially toxic cellular contents into the 
circulation system.  Id. at 1564.  
61. See generally Lynne Smith et al., Effects of Prenatal Methamphetamine Exposure on 
Fetal Growth and Drug Withdrawal Symptoms in Infants Born at Term, 24 J. DEVELOPMENTAL 
BEHAV. PEDIATRICS 17 (2003). 
62. See generally Amelia Arria et al., Methamphetamine and Other Substance Use During 
Pregnancy: Preliminary Estimates from the Infant Development, Environment, and Lifestyle 
Study, 10 MATERNAL & CHILD HEALTH J. 293 (2006) (offering preliminary results of the first 
large scale prenatal study). 
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D. EFFECTS ON COGNITIVE/PSYCHIATRIC ASSOCIATIONS 
Methamphetamine abusers have deficiency in the prefrontal cortex, 
which affects working memory and results in poor decision-making, 
impulsivity, and lack of insight.63  Deficits are also found in the anterior 
cingulate gyrus, which causes selective attention spans and causes individ-
uals to appear unmotivated.64  In addition, changes in the temporal lobe 
from methamphetamine use cause episodic memory loss and depression, 
not only while withdrawing use from the drug, but also on-going after 
withdrawal.65 
Methamphetamine-dependent individuals who had been abstinent for 
five to fourteen days performed significantly worse than control subjects on 
“neurocognitive measures sensitive to attention/psychomotor speed, on 
measures of verbal learning and memory, and on executive system 
measures sensitive to fluency.”66  “Recently abstinent methamphetamine-
dependent subjects demonstrated quantitative EEG abnormalities that are 
consistent with a generalized encephalopathy.”67  This type of changes in 
brain electrical activity is commonly associated with a variety of cognitive 
and psychiatric abnormalities.68 
There is some preliminary evidence suggesting that methamphetamine 
dependence may cause long-term neuronal damage and deleterious effects 
on cognitive processes such as memory and attention.69  Methamphetamine 
abusers who remain abstinent for nine months or longer show modest 
improvement in performance on some tests of motor skill and memory and 
they appear to recover from some of the drug’s damaging effects on 
 
63. Edythe London et al., Mood Disturbances and Regional Cerebral Metabolic 
Abnormalities in Recently Abstinent Methamphetamine Abusers, 61 ARCH. GEN. PSYCHIATRY 73, 
73 (2004). 
64. Thomas E. Nordahl et al., Neuropsychological Effects of Chronic Methamphetamine Use 
on Neurotransmitters and Cognition: A Review, 15 J. NEUROPSYCHIATRY AND CLINICAL 
NEUROSCIENCES 317, 321 (2003). 
65. London et al., supra note 63, at 79-80.  Depression is a mood disorder characterized by 
poor appetite or overeating, sleeplessness or hypersomnia, low energy or fatigue, low self-esteem, 
feelings of hopelessness, and difficulty concentrating or making decisions.  STEDMAN’S MEDICAL 
DICTIONARY, supra note 39, at 477-78. 
66. Ari D. Kalechstein et al., Methamphetamine Dependence is Associated with 
Neurocognitive Impairment in the Initial Phases of Abstinence, 15 J. NEUROPSYCHIATRY & 
CLINICAL NEUROSCIENCES 215, 215 (2003).  Executive system functioning is associated with 
mental operations such as planning, working memory, and initiation and self-regulation of goal-
directed behavior.  MAXWELL, RESEARCH FOR TREATMENT, supra note 21, at 5. 
67. Thomas F. Newton et al., Quantitative EEG Abnormalities in Recently Abstinent 
Methamphetamine Dependent Individuals, 114 CLINICAL NEUROPHYSIOLOGY 410, 410 (2003). 
68. Id. 
69. Nordahl et al., supra note 64, at 317. 
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metabolism in the thalamus.70  Drug-related deficits appear to persist 
longer, however, in the striatum, which “could reflect long-lasting changes 
in dopamine cell activity and decreases in the nucleus accumbens that could 
account for the persistence of amotivation and anhedonia in detoxified” 
patients.71  Methamphetamine users who had been abstinent six months or 
longer had significantly greater prefrontal gray matter density than short-
term abstinent users, but less than healthy comparison subjects.72 
Methamphetamine also produces long-term changes in dopamine 
neurons in the striatum.73  Decreases were noted in several measures of 
cognitive function in former methamphetamine users as compared to con-
trols.74  However, the magnitude of the differences was small, which should 
lead to a more optimistic attitude on the part of treatment practitioners and 
those in recovery from methamphetamine abuse/dependence.75 
Using magnetic resonance imaging (MRI) and new computational 
brain mapping techniques, Thompson demonstrated systematic brain 
structural deficits with chronic methamphetamine abuse in human subjects 
and related these deficits to cognitive impairment.76  MRI-based maps 
suggest that chronic methamphetamine abuse causes a selective pattern of 
cerebral deterioration that contributes to impaired memory performance.77 
One study of methamphetamine users found those users who had 
schizoid/schizotypical personalities prior to use of methamphetamine were 
predisposed to develop psychoses.78  Those with psychosis were younger at 
first use, used larger amounts, and possessed significantly higher mean 
Premorbid Schizoid and Schizotypal Trait scores.79  In addition, the meth-
 
70. Gene-Jack Wang et al., Partial Recovery of Brain Metabolism in Methamphetamine 
Abusers After Protracted Abstinence, 161 AM. J. PSYCHIATRY 242, 245 (2004). 
71. Id. at 244-45. Anhedonia is the inability to gain pleasure from normally pleasurable 
experiences.  STEDMAN’S MEDICAL DICTIONARY, supra note 39, at 88.  
72. Id.  Gray matter density is the neural tissue, especially of the brain and spinal cord, that 
contains cell bodies as well as nerve fibers, has a brownish gray color, and forms most of the 
cortex and nuclei of the brain, the columns of the spinal cord, and the bodies of ganglia.  
MAXWELL, RESEARCH FOR TREATMENT, supra note 21, at 5. 
73. Chris-Ellyn Johnson et al., Cognitive Function and Nigrostriatal Markers in Abstinent 
Methamphetamine Abusers, 185 PSYCHOPHARMACOLOGY 327, 327 (2006). 
74. Id. 
75. Id. 
76. Paul M. Thompson et al., Structural Abnormalities in the Brains of Human Subjects who 
Use Methamphetamine, 24 J. NEUROSCIENCE 6028, 6028-6036 (2004). 
77. Id. 
78. C. K. Chen et al., Pre-morbid Characteristics and Co-Morbidity of Methamphetamine 
Users With and Without Psychosis, 33 PSYCHOL. MED. 1407, 1407-1414 (2003). 
79. Id. 
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amphetamine users maintained higher rates of depressive disorder, alcohol 
dependence, and antisocial personality disorders.80 
E. EFFECTS OF METHAMPHETAMINE ON THE FAMILY 
Maternal drug use, or use of drugs by mothers, is associated with risk 
factors such as poverty, chaotic and dangerous lifestyles, symptoms of 
psychopathology, history of childhood sexual abuse, and involvement in 
difficult or abusive relationships with male partners.81  It is also associated 
with being single, less educated, having attended less than eleven prenatal 
visits if pregnant, and being on public financial assistance.82  High-risk 
pregnant women should receive targeted interventions to reduce serious 
adverse outcomes associated with prenatal alcohol and tobacco use as well 
as methamphetamine use.83 
Children are frequently found at the scene of methamphetamine labo-
ratories and are exposed to toxic chemicals and fumes through absorption, 
inhalation, or ingestion.84  In such cases, the homes maintain poor sanita-
tion, hygiene, and nutrition.85  Methamphetamine may also cause high 
incidence of developmental delays in children.86  In these instances, the 
child welfare system often becomes involved and child protective services 
and other social work agencies need protocols to address the needs of the 
children and their parents, as well as those of the legal system.87 
IV. METHAMPHETAMINE TREATMENT 
A. OVERVIEW OF NEED FOR SPECIAL APPROACHES FOR 
METHAMPHETAMINE TREATMENT 
A study of clients treated in a large state treatment system between 
1992 and 2002, found risk factors for noncompletion and shorter treatment 
retention in both residential and outpatient treatments.88  Some of these 
 
80. Id. 
81. Trecka Wouldes et al., Maternal Methamphetamine Use During Pregnancy and Child 
Outcome: What Do We Know?, 117 NEW ZEALAND MED. J. 1, 1-10 (2004). 
82. Id. 
83. Arria et al., supra note 62, at 293-302.  
84. MAXWELL, RESEARCH FOR TREATMENT, supra note 21, at 3.  
85. Id. 
86. Melinda Hohman et al., Methamphetamine Abuse and Manufacture: The Child Welfare 
Response, 49 SOC. WORK 373, 373-381 (2004). 
87. Id. 
88. See generally Mary-Lynn Brecht et al., Methamphetamine Treatment: Trends and 
Predictors of Retention and Completion in a Large State Treatment System, 29 J. SUBSTANCE 
ABUSE TREATMENT 295, 295 (2006). 
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include having lower than a high school education, being younger at 
admission, having a disability, having greater severity of methamphetamine 
use, and injecting drugs.89  Clients with legal supervision at admission had 
higher completion rates and longer retention than those reporting no legal 
status.90  Overall, clients with greater socioeconomic disadvantage and 
more severe problems required more services to be retained in treatment.91 
Treatment for methamphetamine abuse is based on previous treatment 
approaches for cocaine abuse.92  But there are some aspects of metham-
phetamine-related disorders that are specific to the consequences of using 
that drug.93  Given the cognitive problems seen in some methamphetamine 
users, law enforcement agencies and treatment providers should make 
certain specific efforts with methamphetamine users.94  For instance, 
relevant information as to compliance, types of help, and possible conse-
quences for compliance-failure should be made readily available to all 
interested parties, including the user.95  Physicians and other health profes-
sionals should make certain that the patient understands the medical advice 
and also has “a method for remembering to take medications and to comply 
with suggested medical procedures.”96 Also, treatment providers should 
offer concrete and specific information as to the particular type of 
treatment.97 
The development of treatments is particularly critical for a number of 
user groups including those who experience persistent psychosis, pregnant 
women and women with children, gay and bisexual men, and users 
involved in the criminal justice system.98  Similarly, rural populations, 
Hispanics, and youths are groups of individuals particularly in need of 
special consideration.99  For instance, a randomized controlled trial of 
methamphetamine-dependent gay and bisexual males found that treatment 
that focused on both drug use and risky sexual behaviors in a gay-friendly 
setting produced significant reductions in methamphetamine use and sexual 
 
89. Id. 
90. Id. 
91. Id. 
92. Cretzmeyer et al., supra note 35, at 267. 
93. See Sara L. Simon et al., Cognitive Performance of Current Methamphetamine and 
Cocaine Abusers, 21 J. ADDICTIVE DISEASES 61, 71 (2002) (stating that methamphetamine users 
cognitive manipulation of information differs from that of cocaine users). 
94. Id. 
95. Id. 
96. Id. 
97. Id. 
98. Richard A. Rawson et al., Treatment of Methamphetamine Use Disorders: An Update, 23 
J. SUBSTANCE ABUSE TREATMENT 145, 148-49 (2003). 
99. Id. at 145. 
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risk behaviors.100  Drug treatment merits consideration as a primary HIV 
prevention strategy for this population.101 
B. THE MATRIX MODEL 
The Matrix Model is a comprehensive package that provides substance 
abuse treatment professionals with a year-long intensive outpatient model 
for clients and their families.102  This model calls for sixteen weeks of 
structured programming and thirty-six weeks of continuing care.103  Clients 
receive information, assistance in structuring a substance-free lifestyle, and 
support to achieve and maintain abstinence from drugs and alcohol.104  The 
program specifically focuses on clients who are dependent on methamphet-
amine and cocaine, as well on the families of these clients.105 
The Matrix Model calls for follow-ups at seventeen, twenty-six, and 
fifty-two weeks.106  Between sixty-six and sixty-nine percent of clients who 
had been treated under the Matrix Model had methamphetamine-free urine 
samples.107  The evaluations continue to support the value of integrated 
treatment for co-occurring conditions, and especially the importance of 
training counseling staff to handle psychotic symptoms when needed.108 
The Matrix Approach was developed by the Matrix Institute in Los 
Angeles and adapted by the Substance Abuse and Mental Health Services 
Administration’s  (SAMHSA) Center for Substance Abuse Treatment.109 
 
100. Steven Shoptaw et al., Behavioral Treatment Approaches for Methamphetamine 
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109. Copies of the treatment package are available free of charge from SAMHSA’s National 
Clearinghouse for Alcohol and Drug Information at 800-729-6686 or electronically through 
www.ncadi.samhsa.gov. 
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V. CONCLUSION 
The methamphetamine user poses a challenge for both the public safety 
and health sectors.  Extensive evaluations have shown that treatment works, 
but the cognitive difficulties that many users exhibit after ceasing 
methamphetamine use must be acknowledged and worked with during the 
early stages of treatment.  In addition, special programs and approaches 
should be developed for high risk populations such as women, people who 
are dually addicted to methamphetamine and sex, and adolescents.  Public 
safety officials should be aware of the cognitive problem in their dealings 
with methamphetamine users. 
